pka inhibitor pki 14-22 #2546 (Tocris)
Structured Review
Pka Inhibitor Pki 14 22 #2546, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pka+inhibitor+pki/pki+14+22+amide/pmc11543937-240-8-14
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration. Article Snippet: In TEM assays where ECs were treated with various inhibitors, before the addition of PBMCs, HUVECs were preincubated with the following inhibitors in preconditioned media for 1 h at 37°C: Article Title: Age-Dependent D1-D2 Receptor Coactivation in the Lateral Orbitofrontal Cortex Potentiates NMDA Receptors and Facilitates Cognitive Flexibility. Article Snippet: Protein kinase A (PKA) inhibitor (PKI; 20 μM; Tocris), Molecular Weight:Article Title: Activation of InsP 3 receptors is sufficient for inducing graded intrinsic plasticity in rat hippocampal pyramidal neurons Article Snippet: .. Drugs used in the experiments were d -myo-InsP 3 (InsP 3 ; Sigma Aldrich or Tocris Bioscience), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 10 μM (+)bicuculline, 10 μM picrotoxin, 50 μM d,l -2-amino-5-phosphonovaleric acid ( d,l -APV), and 2 μM {"type":"entrez-protein","attrs":{"text":"CGP55845","term_id":"875097176","term_text":"CGP55845"}} CGP55845 (all synaptic blockers from Allied Scientific), 50 μM NiCl 2 (Sigma-Aldrich), 10 μM nimodipine (Tocris Bioscience), 1 mg/ml heparin (20,000–25,000 molecular weight; Calbiochem), 20 μM ZD7288 (Tocris Bioscience), 20 mM BAPTA (Life Technologies), 20 μM Incubation:Article Title: Calcium/calmodulin‐dependent kinase II and nitric oxide synthase 1‐dependent modulation of ryanodine receptors during β‐adrenergic stimulation is restricted to the dyadic cleft Article Snippet: .. The Transferring:Article Title: Calcium/calmodulin‐dependent kinase II and nitric oxide synthase 1‐dependent modulation of ryanodine receptors during β‐adrenergic stimulation is restricted to the dyadic cleft Article Snippet: .. The Transfection:Article Title: Characterization of a Threonine-Rich Cluster in Hepatitis C Virus Nonstructural Protein 5A and Its Contribution to Hyperphosphorylation Article Snippet: 20 21 Pharmacological inhibition of NS5A phosphorylation 22 Huh7-Lunet T7 cells were seeded with a density of 2x106 cells per 6-Well dish and 23 transfected 24 h later with LT1 transfection agent (Mirus Bio LLC, Madison, WI, USA) 24 according to manufacturer’s instruction. .. For drug treatment the supernatant was replaced 4 h 25 on S eptem ber 28, 2018 by guest http://jvi.asm .org/ D ow nloaded from 10 after transfection with complete DMEM containing either 5 μM of the PI4KA inhibitor G1 1 (GlaxoSmithKline, Munich, Germany) (60), 10 μM of the CKIα inhibitor H479 (61), 500nM 2 of the CKII inhibitor TBBz (Sigma-Aldrich, Darmstadt, Germany) (62), 30 μM of the Polo-3 like Kinase 1 inhibitor Poloxin (Sigma-Aldrich, Darmstadt, Germany) (63),100 nM of the 4 Polo-like Kinase 2/3 inhibitor TC-S 7005 (Tocris, Wiesbaden-Nordenstadt, Germany), 1 μM 5 GSK3 inhibitor BIO (Sigma-Aldrich, Darmstadt, Germany) (64),10 μM Concentration Assay:Article Title: SYK kinase mediates brown fat differentiation and activation Article Snippet: .. SYK-i1/ER27319 (Tocris Bioscience), SYK-i2/BAY61-3606 (Sigma-Aldrich), SYK-i3/R406 (free base, Selleck Chemicals #S1533), SYK-i4/PRT062607 (Selleck Chemicals #S8032) and SHP1 inhibitor 3AC (EMD Millipore #5658351) were reconstituted in DMSO and stored at −80 °C. mTOR inhibitors (Torin 1, torin 2, KU0063794), Akt inhibitor API-2, |


![S. cerevisiae Sup35p is phosphorylated by <t>PKA</t> in vitro . Proteins were incubated with the PKA catalytic subunit and [γ- 32 P]ATP, submitted to SDS-PAGE, and visualized by autoradiography. (a) Phosphorylation of wild-type Sup35p in the presence of PKA or <t>PKI.</t> (b) Phosphorylation of A and D mutant proteins by PKA. (c) Recognition of the different proteins by a specific PKA-phosphorylated substrate antibody. Wild-type, A or D mutant proteins were phosphorylated or not by PKA before western blotting and detection using a secondary antibody linked to the alkaline phosphatase. (d) Phosphorylation of C-terminal proteins by PKA.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_9375/pmc02259375/pmc02259375__1471-2199-9-22-2.jpg)